Quantcast


Last updated: March 16. 2013 11:01PM - 116 Views

Story Tools:

Font Size:

Social Media:
bd6f34b2e7c94403a7effc0868412730.jpg



(AP) Anglo-Swedish pharmaceutical company AstraZeneca PLC warned over expiring patents on its medicines as the company announced a 37 percent fall in full-year net profit.


AstraZeneca said that its net profit fell to $6.3 billion in the year ended Dec. 31, compared with nearly $10 billion in 2011. The company blamed the loss of exclusivity on several big-name drugs for a drop in revenue to $28 billion from $33.6 billion a year earlier.


In one example, U.S. revenue fell 21 percent, largely due to competition from generic versions of AstraZeneca's anti-depression medication Seroquel IR.


Chief executive Pascal Soriot said Thursday the company's 2012 performance reflects a period of significant patent expiry and tough market conditions.


He said the company's new leadership team would focus on the company's brands and product pipeline.


Associated Press
Comments
All user comments are subject to our Terms of Service. Users may flag inappropriate comments.
comments powered by Disqus



Featured Businesses


Poll



Info Minute



Gas Prices

Wilkes-Barre Gas Prices provided by GasBuddy.com